3 results match your criteria: "Zhumadian City Central Hospital[Affiliation]"
Cancer Cell Int
February 2021
Department of Medical Laboratory, Zhumadian City Central Hospital, No. 747 Zhonghua Avenue, Yicheng District, Zhumadian, 463000, Henan, China.
Background: Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer, with a poor prognosis. The roles of circular RNAs (circRNAs) in tumors have been initially clarified. In this study, we probed into the functions and underlying molecular mechanisms of circ-ANXA7 in LUAD.
View Article and Find Full Text PDFDrug Deliv
December 2020
Department of General Practice, Zhumadian City Central Hospital, Zhumadian, China.
GLOBOCAN estimates 36 types of cancers in 185 countries based on the incidence, mortality, and prevalence in the year 2019. Nowadays, chemotherapy is the most widely used cancer treatment among immune, radio, hormone, and gene therapies. Here, we describe a very simple yet cost-effective approach that synergistically combines drug reconstitution, supramolecular nano-assembly, and tumor-specific targeting to address the multiple challenges posed by the delivery of the chemotherapeutic Gemcitabine (GEM) drug.
View Article and Find Full Text PDFInt J Clin Exp Pathol
December 2016
Department of Surgical, Zhumadian City Central Hospital Zhumadian 463000, P.R. China.
The present study demonstrates the effect of rubriflordilactone on lipopolysaccharide (LPS)-induced acute kidney injury in rats and MLE-15 cells. LPS administration in rats resulted in formation of edema which was inhibited by pretreatment with rubriflordilactone. The pulmonary tissues of LPS administered rats and MLE-15 cells showed a significant increase in the expression of matrix metalloproteinase-9, interleukin-6 and inducible nitric oxide synthase.
View Article and Find Full Text PDF